{"disease":{"id":"unexplained-chronic-cough","name":"unexplained chronic cough"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06504446","title":"Study to Assess the Efficacy, Safety, and Tolerability of NOC-110 in Adults With Refractory or Unexplained Chronic Cough","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":455,"lead_sponsor_name":"Nocion Therapeutics","has_results":false},{"nct_id":"NCT04562155","title":"Clinical Study to Evaluate the Efficacy and Safety of Three Different Doses of BAY1817080 Compared to Placebo in Patients With Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":310,"lead_sponsor_name":"Bayer","has_results":true},{"nct_id":"NCT06960759","title":"Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":135,"lead_sponsor_name":"University of Montana","has_results":false},{"nct_id":"NCT05265871","title":"ATP Level and Cough Sensitivity to ATP in Subjects With Refractory/Unexplained Chronic Cough","phase":"","overall_status":"COMPLETED","enrollment_count":131,"lead_sponsor_name":"Kefang Lai","has_results":true},{"nct_id":"NCT07288528","title":"A 2x2 Factorial, Randomized, Open-label Trial to Evaluate Neuromodulators and Cough Control Therapy in Patients With Refractory or Unexplained Chronic Cough","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":124,"lead_sponsor_name":"McMaster University","has_results":false},{"nct_id":"NCT05660850","title":"A Study To Evaluate The Efficacy, Safety, Pharmacokinetics, And Pharmacodynamic Effects Of GDC-6599 In Patients With Chronic Cough","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":49,"lead_sponsor_name":"Genentech, Inc.","has_results":true},{"nct_id":"NCT04454424","title":"Study on the Safety of BAY1817080, How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug in Participants With Impaired Liver Function or Normal Liver Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":37,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04265781","title":"Study on the Safety of Drug BAY1817080 at Different Doses and the Way the Body Absorbs and Eliminates the Drug in Japanese Healthy Adult Male Participants","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04471337","title":"Study on the Safety of BAY1817080 How it is Tolerated and the Way the Body Absorbs, Distributes and Gets Rid of the Study Drug Given to Participants With Moderate Renal Impairment and End Stage Renal Disease Requiring Dialysis Compared With Matched Participants With Normal Renal Function","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"Bayer","has_results":false},{"nct_id":"NCT04487431","title":"A Trial to Learn How a New Liquid Form of BAY1817080 is Tolerated and Taken up by the Body of Healthy Male Participants (Part A). By Labeling BAY1817080 With a Radioactive Substance (Carbon 14) Researchers Want to Learn How the Study Drug is Processed and Excreted by the Body After Dosing (Part B)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":14,"lead_sponsor_name":"Bayer","has_results":false}],"total":10},"guidelines":[],"source":"Drug Landscape verified database"}